Investor Presentaiton slide image

Investor Presentaiton

Industry-leading product portfolio with revolutionary technology GUARDANT 360CDX 1st FDA-Approved Comprehensive Liquid Biopsy GUARDANT 360 Next-Generation Liquid Biopsy Assay GUARDANT GUARDANTREVEAL 1st Blood-Only Recurrence Monitoring Assay Reimbursed by Medicare INVESTOR 20 DAY 23 GUARDANT 360 TissueNext Next-Generation Tissue Assay GUARDANT 360 Response 1st Blood-Only Liquid Biopsy to Monitor Tx Response 79
View entire presentation